mammary gland hyperplasia with breast pain
Conditions
Interventions
Treatment group 1:Drug intervention 1
Treatment group 2:Drug intervention 2
Control group:Placebo
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for mammary hyperplasia; 2. Have a history of cyclic premenstrual breast pain with a VAS pain score = 4 points; 3. Female aged 18–65 years (inclusive); 4. Have not used hormonal preparations, oral contraceptives, or hormone replacement therapy within the past 6 months; 5. Have normal, unbroken skin on the breasts; 6. Voluntarily agree to participate in the clinical trial and sign the informed consent form
Exclusion criteria
Exclusion criteria: 1. Patients with mastitis, malignant breast tumors, or other breast diseases requiring surgical intervention; 2. Patients who have previously undergone breast plastic surgery or breast surgery within the past 3 months; 3. Patients with severe primary diseases of the cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic systems; or peptic ulcer disease; or severe life-threatening illnesses (e.g., malignancy, acquired immunodeficiency syndrome [AIDS]); or patients with mental or legal disabilities; 4. Anterior or lateral chest pain caused by other diseases; 5. Pregnant or lactating women, or women planning pregnancy within the next 3 months; 6. Patients with allergic diathesis or known hypersensitivity to any components of the study medication; 7. Patients with other conditions that, in the investigator's opinion, may reduce the likelihood of enrollment or complicate participation, such as circumstances prone to loss to follow-up (e.g., unstable work environment), or those unable to provide adequate informed consent due to mental and behavioral disorders; 8. Patients who have participated in another clinical trial within the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Short-form McGill Pain Questionnaire(SF-MPQ); | — |
Secondary
| Measure | Time frame |
|---|---|
| Short-form McGill Pain Questionnaire(SF-MPQ); | — |
Countries
China
Contacts
Public ContactQianjun Chen
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed